Anusionwu Obiora, Calkins Hugh
Division of Hospital Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
J Atr Fibrillation. 2013 Feb 12;5(5):680. doi: 10.4022/jafib.680. eCollection 2013 Feb-Mar.
Atrial fibrillation has evolved from being a novel unproven procedure to being an important treatment option for patients with symptomatic atrial fibrillation. Atrial fibrillation ablation is an appropriate treatment option for patients with symptomatic atrial fibrillation, particularly if they have failed one or more trials of antiarrhythmic drug therapy. While much has been learned about the optimal technique and outcomes for catheter ablation of paroxysmal atrial fibrillation; catheter ablation of atrial fibrillation in patients with long standing persistent atrial fibrillation remains in its infancy. The following objectives would be accomplished in this review article. First, we will review the various ablation strategies, which have been employed and proposed for ablation of long standing persistent atrial fibrillation. Second, the methodology, results and outcomes of the major studies were reviewed in detail, which have reported outcomes of ablation in this patient population. And finally, some conclusions were drawn regarding where we stand and where the knowledge gaps remain as we seek to improve ablation outcomes in this population of AF patients.
心房颤动已从一种未经证实的新手术发展成为有症状心房颤动患者的重要治疗选择。心房颤动消融术是有症状心房颤动患者的一种合适治疗选择,特别是对于那些抗心律失常药物治疗一次或多次试验失败的患者。虽然关于阵发性心房颤动导管消融的最佳技术和结果已了解很多,但长期持续性心房颤动患者的心房颤动导管消融仍处于起步阶段。本文将实现以下目标。首先,我们将回顾已采用和提出的用于长期持续性心房颤动消融的各种消融策略。其次,详细回顾了主要研究的方法、结果和结局,这些研究报告了该患者群体的消融结果。最后,就我们目前的状况以及在寻求改善这类心房颤动患者消融结果时仍存在的知识空白得出了一些结论。